Stephen Worland

Form D signer

Stephen Worland

Chief Executive Officer at Atomwise

Form D signer

Capital raised by Atomwise

$64.1M+$19.8M latest round

2 Form D filings · first filed Mar 2024 · San Francisco, CA

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 2
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 1 ↗

Career

1 company on file

AtomwiseBiotech · San Francisco, CAsince Mar 2024

Chief Executive Officer

Signatory on Atomwise's Form D filings · $64.1M raised across 2

Company filings

via EDGAR · Form D for Atomwise2

DateCompanyFormAmountRole on filing

Mar 10, 2026AtomwiseForm D+$19.8MChief Executive Officer

Form DMar 10, 2026 · Atomwise+$19.8Mas Chief Executive Officer

Mar 8, 2024AtomwiseForm D+$44.3MChief Executive Officer

Form DMar 8, 2024 · Atomwise+$44.3Mas Chief Executive Officer

Overview

Last filing Mar 10, 2026

Stephen Worland is on file as Chief Executive Officer at Atomwise in San Francisco, CA. Atomwise has 2 Form D filings on record, $64.1M raised in total. Stephen Worland appears as a signatory on the company's filings.

Teammates

Atomwise · 1

Yan ZhaoExecutive Officer

Products

Atomwise · 1

AtomNetDrug Discovery

AtomNet is an advanced AI-powered drug discovery platform that utilizes deep learning algorithms and convolutional neural networks to predict interactions between small molecules and protein targets. This cutting-edge technology enables the virtual screening of billions of chemical compounds, rapidly identifying the most promising candidates for further development.